Mortality of Cancer Surgery During SARS CoV2 Pandemic

Banaras Hindu University1,576 enrolled

Overview

The impact of cancer surgery during covid epidemic is not clear. The published reports show contradictory findings that extend from no change in mortality to increased mortality, further no data on exposure and outcome of health care worker is available. This study is designed to address the above questions

This is a retrospective study from the prospectively collected data that is extracted from the electronic database of Department of Surgical Oncology, IMS, BHU The data is inform of two cohorts one extending from April 2019-April 2020 and other from May 2020 to May 2021 i.e. pre covid and during covid pandemic

Study Type

OBSERVATIONAL

Enrollment

1,576

Conditions

SARS CoV 2 Infection Cancer

Interventions

SurgeryOTHER

Surgery for cancer as per the stage of the disease and protocol

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients operated during the study period Exclusion Criteria: * None

Locations (1)

Banaras Hindu University

Varanasi, Uttar Pradesh, India

Outcomes

Primary Outcomes

30 day mortality

post operative deaths within one year

Time frame: 30 days

number of participants developing major or minor complications

Surgical complications classified as per Clavien Dindo classification

Time frame: 30 days

Secondary Outcomes

number of health care worker with SARS CoV2 infection

Covid infection in health care workers

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.